Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.8 DKK | +3.26% | +1.02% | -16.12% |
03-13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
03-13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
Sales 2024 * | 5.22B 748M 1.02B | Sales 2025 * | 5.06B 725M 991M | Capitalization | 11.6B 1.66B 2.27B |
---|---|---|---|---|---|
Net income 2024 * | 630M 90.35M 123M | Net income 2025 * | 855M 123M 168M | EV / Sales 2024 * | 2.11 x |
Net cash position 2024 * | 569M 81.66M 112M | Net cash position 2025 * | 861M 123M 169M | EV / Sales 2025 * | 2.12 x |
P/E ratio 2024 * |
18.3
x | P/E ratio 2025 * |
13.6
x | Employees | 1,379 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.85% |
Latest transcript on Bavarian Nordic A/S
1 day | +3.26% | ||
1 week | +1.02% | ||
Current month | -3.94% | ||
1 month | -4.03% | ||
3 months | -4.49% | ||
6 months | +14.68% | ||
Current year | -16.12% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Chaplin
CEO | Chief Executive Officer | 57 | 98-12-31 |
Henrik Juuel
DFI | Director of Finance/CFO | 59 | 18-10-31 |
Russell Thirsk
COO | Chief Operating Officer | 56 | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 10-04-26 | |
Director/Board Member | 57 | 22-12-31 | |
Frank Verwiel
BRD | Director/Board Member | 62 | 16-04-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 148.8 | +3.26% | 291,607 |
24-04-25 | 144.2 | -3.58% | 438,710 |
24-04-24 | 149.5 | -1.06% | 264,387 |
24-04-23 | 151.1 | +0.67% | 339,056 |
24-04-22 | 150.1 | +1.87% | 421,064 |
Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 10:59 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.12% | 1.66B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BAVA Stock